244 related articles for article (PubMed ID: 22177409)
21. New di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, growth inhibitory activity on human tumor cell lines and non-tumor cells, effects on cell cycle and on programmed cell death.
Queiroz MJ; Peixoto D; Calhelha RC; Soares P; Dos Santos T; Lima RT; Campos JF; Abreu RM; Ferreira IC; Vasconcelos MH
Eur J Med Chem; 2013 Nov; 69():855-62. PubMed ID: 24121236
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
[TBL] [Abstract][Full Text] [Related]
23. Novel 3',5'-diprenylated chalcones inhibited the proliferation of cancer cells in vitro by inducing cell apoptosis and arresting cell cycle phase.
Wen Z; Zhang Y; Wang X; Zeng X; Hu Z; Liu Y; Xie Y; Liang G; Zhu J; Luo H; Xu B
Eur J Med Chem; 2017 Jun; 133():227-239. PubMed ID: 28390228
[TBL] [Abstract][Full Text] [Related]
24. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and anti breast cancer activity of biphenyl based chalcones.
Sharma A; Chakravarti B; Gupt MP; Siddiqui JA; Konwar R; Tripathi RP
Bioorg Med Chem; 2010 Jul; 18(13):4711-20. PubMed ID: 20605470
[TBL] [Abstract][Full Text] [Related]
26. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of benzo[d][1,3]dioxol-5-yl chalcones as antiproliferating agents.
Kamal A; Balakrishna M; Loka Reddy V; Riyaz S; Bagul C; Satyanarayana BM; Venkateswar Rao J
Chem Biol Drug Des; 2015 Nov; 86(5):1267-84. PubMed ID: 26032623
[TBL] [Abstract][Full Text] [Related]
28. Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line.
Konieczny MT; Konieczny W; Sabisz M; Skladanowski A; Wakieć R; Augustynowicz-Kopeć E; Zwolska Z
Eur J Med Chem; 2007 May; 42(5):729-33. PubMed ID: 17300856
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antitumor activity of novel nitrogen mustard-linked chalcones.
Fang X; Yang B; Cheng Z; Yang M; Su N; Zhou L; Zhou J
Arch Pharm (Weinheim); 2013 Apr; 346(4):292-9. PubMed ID: 23519571
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones.
Yamali C; Gul HI; Ozgun DO; Sakagam H; Umemura N; Kazaz C; Gul M
Anticancer Agents Med Chem; 2017; 17(10):1426-1433. PubMed ID: 28356013
[TBL] [Abstract][Full Text] [Related]
31. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2009 Dec; 17(23):7909-14. PubMed ID: 19875299
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
Kupcewicz B; Jarzęcki AA; Małecka M; Krajewska U; Rozalski M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4260-5. PubMed ID: 25091929
[TBL] [Abstract][Full Text] [Related]
34. Chalcones incorporated pyrazole ring inhibit proliferation, cell cycle progression, angiogenesis and induce apoptosis of MCF7 cell line.
Mohamed MF; Mohamed MS; Fathi MM; Shouman SA; Abdelhamid IA
Anticancer Agents Med Chem; 2014; 14(9):1282-92. PubMed ID: 25323033
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and selective cytotoxic activity of novel hybrid chalcones against prostate cancer cells.
Nagaraju M; Gnana Deepthi E; Ashwini C; Vishnuvardhan MV; Lakshma Nayak V; Chandra R; Ramakrishna S; Gawali BB
Bioorg Med Chem Lett; 2012 Jul; 22(13):4314-7. PubMed ID: 22668451
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and cytotoxicity of 2-phenylquinazolin-4(3H)-one derivatives.
Rhee HK; Yoo JH; Lee E; Kwon YJ; Seo HR; Lee YS; Choo HY
Eur J Med Chem; 2011 Sep; 46(9):3900-8. PubMed ID: 21704436
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents.
Bandgar BP; Gawande SS; Bodade RG; Totre JV; Khobragade CN
Bioorg Med Chem; 2010 Feb; 18(3):1364-70. PubMed ID: 20064725
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of some pyrazolines and pyrimidines derived from polymethoxy chalcones as anticancer and antimicrobial agents.
Rostom SA; Badr MH; Abd El Razik HA; Ashour HM; Abdel Wahab AE
Arch Pharm (Weinheim); 2011 Sep; 344(9):572-87. PubMed ID: 21755528
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and structure-activity relationship studies of furan-ring fused chalcones as antiproliferative agents.
Saito Y; Kishimoto M; Yoshizawa Y; Kawaii S
Anticancer Res; 2015 Feb; 35(2):811-7. PubMed ID: 25667461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]